Justine Habault
Hôpital St. Louis
Paris, 75010, France
Paris, 75010, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
MDM2 suppresses c-Myc synthesis by binding to the 5' mRNA translation regulatory sequence.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: June 23, 2026
The codon context provides cis-acting immune evasion for the human papilloma virus (HPV) E6.
Journal: RNA (New York, N.Y.)
Published: January 13, 2025
Translation of bi-directional transcripts enhances MHC-I peptide diversity.
Journal: Frontiers in immunology
Published: January 02, 2025
In Vivo Efficacy of a Macrocyclic Peptoid-Peptide Hybrid That Selectively Modulates the Beta-Catenin/TCF Interaction to Inhibit Prostate Cancer.
Journal: The Prostate
Published: October 28, 2024
A Multivalent Peptoid Conjugate Modulates Androgen Receptor Transcriptional Activity to Inhibit Therapy-resistant Prostate Cancer.
Journal: Molecular cancer therapeutics
Published: March 30, 2023
PAK1-Dependent Antitumor Effect of AAC-11‒Derived Peptides on Sézary Syndrome Malignant CD4+ T Lymphocytes.
Journal: The Journal of investigative dermatology
Published: September 07, 2020
Efficient Therapeutic Delivery by a Novel Cell-Penetrating Peptide Derived from Acinus.
Journal: Cancers
Published: June 19, 2020
Prophylactic and therapeutic antileukemic effects induced by the AAC-11-derived Peptide RT53.
Journal: Oncoimmunology
Published: August 06, 2019
Recent Advances in Cell Penetrating Peptide-Based Anticancer Therapies.
Journal: Molecules (Basel, Switzerland)
Published: January 28, 2019
The anticancer peptide RT53 induces immunogenic cell death.
Journal: PloS one
Published: March 16, 2018
Showing 1-12 of 12
Last Updated: 09/26/2026